Hoth Therapeutics, Inc. Series B Preferred Stock SUBSCRIPTION AND INVESTMENT REPRESENTATION AGREEMENTSubscription and Investment Representation Agreement • November 3rd, 2022 • Hoth Therapeutics, Inc. • Pharmaceutical preparations • Nevada
THIS AGREEMENT (this “Agreement”), dated as of November 2, 2022, is by and between Hoth Therapeutics, Inc., a Nevada corporation (the “Company”), and the undersigned subscriber (the “Subscriber”). In consideration of the mutual promises contained herein, and other good, valuable and adequate consideration, the parties hereto agree as follows:
